London pre-open: Stocks set to dip, focus on US CPI and Fed

Alexander Bueso WebFG News | 13 Oct, 2017 07:49 - Updated: 07:52 | | |


Stocks are seen starting the session slightly lower, tracking similar losses on Wall Street overnight, despite the release of stronger-than-expected Chinese foreign trade data released overnight.

The Footsie was being called to begin the Friday session 11 points lower at 7,545.

On Thursday, the top flight index had notched up a fresh record high even as traders waited on US consumer price data to be released on Friday which might help consolidate expectations for a US central bank interst rate hike in December.

"Yesterday’s PPI data for September would also appear to suggest that price pressures are picking up and if today’s headline CPI number follows suit, then it would be a major surprise if US policymakers were to backtrack on a December rate rise now. It is expected that September CPI will see an uptick from 1.9% to 2.3%.

"For the moment markets are pricing a 76% probability of a move in December, they just aren’t so sure about how many are coming in 2018 and that’s the point," said CMC Markets UK's chief market analyst, Michael Hewson.

Acting as a backdrop, the latest Chinese trade numbers revealed a pick-up in export growth from a 6.9% year-on-year clip in August to 9.0% for September (consensus: 10.9%). Similarly, import demand was stronger than anticipated, rising by 19.5% on the year (consensus: 16.5%), up from 14.4%.

"Today’s figures suggest that not only has strong foreign demand continued to prop up manufacturing activity in China but domestic demand remains resilient too," said Julian Evans-Pritchard at Capital Economics.

Charges to weigh on GKN's bottom line

GKN guided towards full-year profits before tax just slightly ahead of their 2016 level as a result of two significant "comercially sensitive" external claims and continuing headwinds at GKN Aerospace North America, with the latter expected to drag on the group's trading margin. Those two claims were seen resulting in a charge of roughly £40m which would be incurred in the last three months of 2017. Third quarter trading at its aerospace arm was described as "disappointing". Over at its Driveline unit on the other hand, sales were "well ahead" of global industrial production rates which were up 2%. Full-year margins at Driveline were now seen at a similar level as in 2016 due to one of the above claims.

Provident Financial has begun to staunch the blood flow at its doorstep lending business after two profit warnings earlier this year. For the full year the sub-prime lender still expects to make losses of £80-120m before exceptional costs, but said the changes made at its Home Credit business "have prevented any further deterioration in performance", with collections in September recovering to 65% from the 57% in August.

Aviva has agreed to sell its entire 49% shareholding in its joint venture in Taiwan, First Aviva Life, to Aviva's joint venture partner First Financial Holding Company, it announced on Friday. The FTSE 100 insurance company said that, following a strategic review of Aviva Taiwan, it concluded that the business was not central to the group's strategy to focus on markets where it can achieve scale and profitability or have a distinct competitive advantage. It said the transaction had a “negligible impact” on Aviva's IFRS net assets, Solvency II capital position and IFRS operating profit.

Man Group reported solid growth in its funds under management on Friday, with the total standing at $103.5bn as at 30 September compared to $95.9bn on 30 June, and the board claiming rises of 28% in the year to date. The FTSE 250 investment management business said net inflows in the third quarter totalled $2.8bn, which were driven by “strong inflows” into alternative risk premia and emerging market debt strategies. Positive investment movement of $3.3bn was reported in the period.

More news

15 Dec London close: Footsie gains as pound drops, Wall Street hits fresh highs

The top flight index recovered some ground on Friday, but mostly on account of weakness in Sterling after German Chancellor Angela Merkel reportedly echoed other European Union officials, saying "the most difficult phase is ahead of us".

15 Dec Week ahead: US data, Catalan elections in focus

The focus in the coming week will continue to be on the ebb and flow of data out of the US, including Republicans' progress on securing passage of their tax cuts.

15 Dec US open: Stocks jump as Republicans move to secure passage of tax cuts

Wall Street is heading higher again on Friday amid news that Republicans were tweaking their proposed tax cuts in order to secure prompt passage of the US tax bill.

15 Dec Airbus chief executive to step down in board shake-up

The chief executive of French planemaker Airbus will step down from his position in 2019 as the company announced a major shake-up of its management team.

15 Dec FTSE 250 movers: TalkTalk rises but Serco gives back gains

London’s FTSE 250 was up 0.1% to 20,023.23 in afternoon trade on Friday as the Christmas lull kicked in.

15 Dec US industrial production rises slightly less than expected in November

Industrial production in the States rose slightly less quickly than expected last month, despite higher output of business equipment and materials.

15 Dec Strategic Minerals renegotiates acquisition of Leigh Creek Copper Mine

Diversified mineral production and development company Strategic Minerals announced on Friday that, after the successful completion of technical and financial due diligence on the Leigh Creek Copper Mine company, it has agreed to continue with the acquisition on renegotiated terms.

15 Dec FTSE 100 movers: Sky jumps but retailers retreat on H&M sales

London’s FTSE 100 was up 0.3% to 7,469.23 in quiet afternoon trade on Friday.

15 Dec Gfinity partners with Microsoft for next Halo World Championship

International esports entertainment group Gfinity has been named as a preferred event partner to Microsoft for the forthcoming ‘Halo World Championship 2018’ for the next season, it announced on Friday.

15 Dec Hutchison Chi-Med begins fruquintinib trial in US

Hutchison China MediTech, known as Chi-Med, has initiated the United States Phase I bridging clinical trial of fruquintinib, it announced on Friday.